David Windley
Stock Analyst at Jefferies
(3.69)
# 708
Out of 4,667 analysts
187
Total ratings
69.23%
Success rate
14.47%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Downgrades: Hold | $419 → $253 | $295.80 | -14.47% | 18 | Oct 7, 2024 | |
| FTRE Fortrea Holdings | Downgrades: Hold | $25 → $21 | $19.17 | +9.57% | 2 | Sep 25, 2024 | |
| MEDP Medpace Holdings | Downgrades: Hold | $415 → $345 | $333.96 | +3.31% | 5 | Sep 25, 2024 | |
| CI The Cigna Group | Maintains: Buy | $402 → $422 | $325.86 | +29.50% | 17 | Sep 17, 2024 | |
| MOH Molina Healthcare | Maintains: Hold | $354 → $297 | $294.69 | +0.79% | 23 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Hold | $266 → $242 | $194.57 | +24.38% | 4 | Jul 24, 2024 | |
| CNC Centene | Downgrades: Hold | $83 → $69 | $59.24 | +16.48% | 25 | Jul 24, 2024 | |
| UNH UnitedHealth Group | Upgrades: Buy | $481 → $647 | $600.45 | +7.75% | 26 | Jul 17, 2024 | |
| NOTV Inotiv | Downgrades: Hold | $12 → $3.75 | $3.30 | +13.62% | 4 | May 14, 2024 | |
| ELV Elevance Health | Maintains: Buy | $602 → $604 | $401.24 | +50.54% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $547.74 | -31.54% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $12.77 | +21.38% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $212.83 | +26.86% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $9.51 | +63.07% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $314.56 | +70.40% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $18.56 | +56.22% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $44 | $59.62 | -26.20% | 2 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $233 → $203 | $189.50 | +7.12% | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $276 → $302 | $207.94 | +45.23% | 14 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $9.64 | +2,472.61% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.36 | - | 5 | Oct 9, 2017 |
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $295.80
Upside: -14.47%
Fortrea Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $25 → $21
Current: $19.17
Upside: +9.57%
Medpace Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $415 → $345
Current: $333.96
Upside: +3.31%
The Cigna Group
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $325.86
Upside: +29.50%
Molina Healthcare
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $294.69
Upside: +0.79%
IQVIA Holdings
Jul 24, 2024
Downgrades: Hold
Price Target: $266 → $242
Current: $194.57
Upside: +24.38%
Centene
Jul 24, 2024
Downgrades: Hold
Price Target: $83 → $69
Current: $59.24
Upside: +16.48%
UnitedHealth Group
Jul 17, 2024
Upgrades: Buy
Price Target: $481 → $647
Current: $600.45
Upside: +7.75%
Inotiv
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $3.30
Upside: +13.62%
Elevance Health
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $401.24
Upside: +50.54%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $547.74
Upside: -31.54%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $12.77
Upside: +21.38%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $212.83
Upside: +26.86%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $9.51
Upside: +63.07%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $314.56
Upside: +70.40%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $18.56
Upside: +56.22%
Jun 14, 2023
Downgrades: Hold
Price Target: $45 → $44
Current: $59.62
Upside: -26.20%
Mar 28, 2023
Maintains: Hold
Price Target: $233 → $203
Current: $189.50
Upside: +7.12%
Sep 14, 2021
Maintains: Buy
Price Target: $276 → $302
Current: $207.94
Upside: +45.23%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $9.64
Upside: +2,472.61%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.36
Upside: -